NY-MEDIAOCEAN
6.3.2024 10:01:33 CET | Business Wire | Press release
Mediaocean, the mission-critical platform for omnichannel advertising, today announced six new partnerships for its Creative Ad Tech platform, Flashtalking, bringing its market leading solutions to more customers in a range of key markets around the world. The agreements provision for primary ad serving, creative personalization, cross-channel measurement and verification across open web display, mobile, audio, video, digital out-of-home, and connected TV.
Collectively, the new activation partners support advertisers in 89 different countries, significantly expanding Flashtalking’s footprint following a surge in adoption after the announcement that Amazon was deprecating its Sizmek ad server. Each of these companies brings deep experience in the ad serving market, having previously supported brands and agencies using Amazon/Sizmek.
Founded in 2001 and acquired by Mediaocean in 2021, Flashtalking is the leading independent ad tech platform, bridging creative and media teams with intelligent, audience-aware insights and workflows at scale and across channels. The Flashtalking platform provides AI and automation to connect the silos between teams for more efficient production, versioning, and distribution of creative.
The new partners include Tailwind, which operates in 36 markets across Central and South Eastern Europe, the Nordics and Middle East North Africa (MENA), empowering businesses to fast track their marketing with technology integrations, strategic consultation, and professional services, as well as Box Digital, a South Africa-based digital advertising services business with customers spanning 8 sub-Saharan African countries.
A partnership with Adsmovil will bolster Flashtalking’s operations within 33 markets across Latin America (LATAM), through a business uniquely focused on Hispanic and Brazilian audiences which currently serves over 4 billion impressions per month. Meanwhile, a new relationship with Adsonice, will grow Flashtalking’s presence across Europe.
Additionally, an agreement with Escape Velocity, a digital media technology services company that supports agencies and advertisers, will scale Flashtalking in India, Korea, Bangladesh, and Sri Lanka while eTechSol will help serve customers in Pakistan.
Simon Thorne, MD EMEA for Flashtalking, commented: “We’ve seen huge appetite for a truly intelligent, dynamic approach to managing and activating creative campaigns. Advertisers need to enable deep personalization, ensuring the most relevant and impactful brand messages reach the right consumers at the right moment, and they want to do it via a single integrated platform. Today’s announcement really cements our position as being the best solution to deliver that on a global level.”
Coming in the wake of Amazon’s announcement that it will be shuttering its ad serving service, these new partnerships represented a unique opportunity to combine Flashtalking’s best-in-class advertising technology with in-market experts who can offer deep local insights and a highly mature ad serving knowledge base.
Flashtalking was recently named a winner of G2 2024 Best Software Awards for Marketing & Digital Advertising Products based on 300+ authenticated customer reviews. The platform was ranked a leader in Enterprise Creative Management Platforms, Cross-Channel, Video, Mobile, Display, and Social Media Advertising.
Georgia Brammer, MD JAPAC for Flashtalking, added, “We’re thrilled to be able to build these new relationships in so many important markets. We’ve been impressed by the drive and knowledge represented by the teams at all of these businesses. This is, on multiple fronts, a time of change in the global advertising sector and, from conversations with major advertisers, the growth potential we’re seeing in further developing this global network is already proving to be really powerful.”
Odysseas Ntotsikas, Managing Partner of Tailwind, stated, “True to Tailwind’s mission to ‘Drive business fast forward’ the power of creative has proved to be the variable with the biggest impact in an omnichannel marketer’s stack. Through this strategic partnership with global leader Flashtalking, we fortify over a decade of operational excellence in empowering hundreds of regional marketers with creative personalization and digital advertising intelligence to win the only war that matters today, the war for attention.”
Alberto Pardo, Founder & CEO of Adsmovil, said, “We, at Adsmovil, have been committed to driving relevance and value to our clients since our inception. Flashtalking furthers our mission and expands the opportunity to better serve clients with personalization based on real-time variables, driving greater congruence and resonance, and a higher advertiser ROI. We are very excited about our partnership.”
Raghu Seelamsetty, MD of Escape Velocity, added, “Escape is delighted to be partnering with Flashtalking. The partnership is well poised to take advantage of the growth of CTV and social media in these fast growing markets. Flashtalking’s market leading technology combined with Escape’s market reach and service capabilities will enable us to deliver world class solutions to our clients.”
About Flashtalking by Mediaocean
Flashtalking unleashes the power of creative to make media work better. As the leading independent platform for personalization and intelligence across all marketing channels, our Creative Ad Tech bridges the gap between creative and media. We provide AI and automation to connect the silos between teams and deliver more efficient production, versioning, and distribution of creative. Our solutions operate at scale across CTV, Video, Display, Social, Native, Audio, DOOH, and Retail Media channels. As part of Mediaocean, Flashtalking is tied into the industry’s core ad infrastructure for omnichannel planning, buying, and billing. Visit flashtalking.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240305248528/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
